Sort
8,912 grants matching “sars cov 2”
Tissue Factor's Role in the Pathogenesis of Hypercoagulability in COVID-19
$183,750Vijaya Mohan Rao Lella · University Of Texas Hlth Ctr At Tyler · R21 · FY2022 · AI
Novel Designed Multi-Ligands as Tocolytics for Dysregulated Myometrial Pathways in the Treatment of Preterm Labor
$183,750Scott Danielson Barnett · University Of Nevada Reno · R21 · FY2025 · HD
STUDIES OF A SARS-CORONAVIRUS RECEPTOR
$183,744Harvard University (Medical School) · R01 · FY2004 · AI
Development of PROTACs Targeting Papain-like Protease as Broad-Spectrum Anti-Coronavirus Therapeutics
$183,651Shiqing Xu · Texas A&M University · R21 · FY2023 · AI
ST6Gal-1 Sialyltransferase in Inflammation
$183,648Joseph T.y. Lau · Roswell Park Cancer Institute Corp · R01 · FY2020 · AI
Collaborative Research: DMS/NIGMS 1: Identifiability investigation of Multi-scale Models of Infectious Diseases
$183,401Stanca M. Ciupe · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · GM
Array Based Affinity Selection
$183,318Brian Kenneth Kay · Tango Biosciences, Inc. · R41 · FY2020 · GM
Anti-inflammatory activity of hydrogels designed to capture extracellular inflammasomes
$183,186Eva De Alba Bastarrechea · University Of California, Merced · R21 · FY2024 · AI
Repurposing of cancer therapeutics for treatment of patients with COVID-19 disease
$183,000James R. Heath · Institute For Systems Biology · U54 · FY2020 · CA
Directed evolution of polymerases that can read and write extremely long sequences
$182,969Andrew D Ellington · University Of Texas At Austin · R01 · FY2020 · EB
RAPID: The Rise and Propagation of Anti-Vax and Anti-Access Social Media Campaigns Targeted at Disadvantaged and Minority Populations during the COVID19 Pandemic
$182,797Leysia Palen · University Of Colorado At Boulder · · FY2021 · SBE
Temple University Gastroparesis Clinical Center
$182,546Henry P. Parkman · Temple Univ Of The Commonwealth · U01 · FY2025 · DK
Spatiotemporal transcriptomics at the maternal-fetal interface in COVID placenta
$182,500Yuping Wang · Louisiana State Univ Hsc Shreveport · R21 · FY2022 · AI
Project-004
$182,399Stanley Perlman · University Of Iowa · P01 · FY2020 · AI
Project 4
$182,399Stanley Perlman · University Of Iowa · P01 · FY2019 · AI
Project-004
$182,399Stanley Perlman · University Of Iowa · P01 · FY2021 · AI
Effect of vaping on COVID-19 infection
$182,367Carl W White · University Of Colorado Denver · U54 · FY2021 · ES
Background Oriented Schlieren (BOS) Visualization for Evaluation of Risk in Aerosol-Generating Procedures
$182,138Bryan Schmidt · Case Western Reserve University · R21 · FY2022 · EB
RAPID: Viral Particle Disrupting and Sequestering Polymer Materials applied to Coronaviruses
$181,849Dominik Konkolewicz · Miami University · · FY2020 · MPS
Induction of Broad Sarbecovirus Immunity Via A Vaccine Engineered From SARS-CoV-2 Heptad Repeat 1
$181,764Samuel David Stampfer · Emory University · K08 · FY2024 · AI
Induction of Broad Sarbecovirus Immunity Via A Vaccine Engineered From SARS-CoV-2 Heptad Repeat 1
$181,764Samuel David Stampfer · Emory University · K08 · FY2025 · AI
Core--SARS Coronavirus Clone and Reagent
$181,677Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2006 · AI
Consequences of Persistent Immune Activation among ART-treated Women with HIV
$181,575Markella V. Zanni · Massachusetts General Hospital · K24 · FY2023 · AI
Consequences of Persistent Immune Activation among ART-treated Women with HIV
$181,575Markella V. Zanni · Massachusetts General Hospital · K24 · FY2021 · AI
Consequences of Persistent Immune Activation among ART-treated Women with HIV
$181,575Markella V. Zanni · Massachusetts General Hospital · K24 · FY2025 · AI